1
|
Unadkat SV, Padhi BK, Bhongir AV, Gandhi AP, Shamim MA, Dahiya N, Satapathy P, Rustagi S, Khatib MN, Gaidhane A, Zahiruddin QS, Sah R, Serhan HA. Association between homocysteine and coronary artery disease-trend over time and across the regions: a systematic review and meta-analysis. Egypt Heart J 2024; 76:29. [PMID: 38409614 PMCID: PMC10897093 DOI: 10.1186/s43044-024-00460-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Accepted: 02/21/2024] [Indexed: 02/28/2024] Open
Abstract
BACKGROUND The association of homocysteine with coronary artery disease (CAD) has been explored previously with mixed findings. The present Systematic Review and Meta-Analysis (SRMA) has assessed the pooled estimate of association between homocysteine (Hcy) and CAD, and its variation over the period and geography. METHODS Systematic literature search was done in PubMed, Scopus and Cochrane to identify the observational studies that have reported mean Hcy among cases (CAD) and control. The SRMA was registered in PROSPERO (ID-CRD42023387675). RESULTS Pooled standardized mean difference (SMD) of Hcy levels between the cases and controls was 0.73 (95% CI 0.55-0.91) from 59 studies. Heterogeneity was high (I2 94%). The highest SMD was found among the Asian studies (0.85 [95% CI 0.60-1.10]), while the European studies reported the lowest SMD between the cases and controls (0.32 [95% CI 0.18-0.46]). Meta-regression revealed that the strength of association was increasing over the years (Beta = 0.0227, p = 0.048). CONCLUSIONS Higher homocysteine levels might have a significant association with coronary artery diseases, but the certainty of evidence was rated low, owing to the observational nature of the studies, high heterogeneity, and publication bias. Within the population groups, Asian and African populations showed a greater strength of association than their European and American counterparts, and it also increased over the years.
Collapse
Affiliation(s)
- Sumit V Unadkat
- Department of Community Medicine, M. P. Shah Government Medical College, Jamnagar, Gujarat, India
| | - Bijaya K Padhi
- Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - Aparna Varma Bhongir
- Department of Biochemistry, All India Institute of Medical Sciences, Bibinagar, Hyderabad, India
| | - Aravind P Gandhi
- Department of Community Medicine, All India Institute of Medical Sciences, Nagpur, 441108, India.
| | - Muhammad Aaqib Shamim
- Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 342005, India
- Global Center for Evidence Synthesis, Chandigarh, 160036, India
| | - Neelam Dahiya
- Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - Prakasini Satapathy
- Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
- School of Pharmacy, Graphic Era Hill University, Dehradun, 248001, India
| | - Sarvesh Rustagi
- School of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India
| | - Mahalaqua Nazli Khatib
- Division of Evidence Synthesis, Global Consortium of Public Health and Research, DMIHER, Wardha, India
| | - Abhay Gaidhane
- Jawaharlal Nehru Medical College, One Health Centre (COHERD), Datta Meghe Institute of Higher Education, Wardha, India
| | - Quazi Syed Zahiruddin
- Division of Evidence Synthesis, School of Epidemiology and Public Health and Research, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education, Wardha, India
| | - Ranjit Sah
- Tribhuvan University Teaching Hospital, Kathmandu, 46000, Nepal
- Department of Clinical Microbiology, DY Patil Medical College, Hospital and Research Centre, DY Patil Vidyapeeth, Pune, 411000, Maharashtra, India
| | | |
Collapse
|
2
|
Mehani SHM. Novel molecular biomarkers’ response to a cardiac rehabilitation programme in patients with ischaemic heart diseases. EUROPEAN JOURNAL OF PHYSIOTHERAPY 2018. [DOI: 10.1080/21679169.2018.1464597] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- Sherin H. M. Mehani
- Physical Therapy Department for Internal Medicine, Faculty of Physical Therapy, Beni - Suef University, Beni-Suef Governorate, Egypt
| |
Collapse
|
3
|
Chalghoum A, Noichri Y, Dandana A, Baudin B, Miled A, Ferchichi S. Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients. BMC Cardiovasc Disord 2016; 16:244. [PMID: 27894250 PMCID: PMC5127035 DOI: 10.1186/s12872-016-0417-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2016] [Accepted: 11/16/2016] [Indexed: 11/29/2022] Open
Abstract
Background The correct understanding of the biochemical and metabolic interactions between coronary risk factors contribute to the exploration of cardiovascular pathophysiology and improves therapeutic care. The aim of this study was to explore the endothelin-1 (ET-1) concentration and the angiotensin converting enzyme (ACE) activity among Tunisian patients with coronary heart disease, and to investigate the metabolic relationships between these two markers,… and to assess the possible relationship between them and the different risk factors. In this present study, ET-1 concentration was determined by an analytical method (High Performance Chromatography, coupled by Mass Spectrometry), ACE activity was measured by a kinetic method for patients and healthy controls. These subjects (157 patients and 142 controls) beneficed also by a biochemical exploration (lipid, apolipoproteins and glucose profiles) to quantify cardiovascular risk. Results A statistically significant increase of the ET-1 concentration was found among patients compared to healthy controls (15.2 ± 5.3 nM vs 7.1 ± 2.7 nM, p < 0,00001). For the ACE activity, in spite the treatment of the majority of patients (97%) with ACE inhibitors, this activity was statistically elevated in patients compared to healthy subjects (86.7 ± 25.4 IU/L vs 42.8 ± 12.1 IU/L, p < 0.00001). Furthermore, a statistically positive correlation was identified between these two cardiac markers (r = 0.68 p < 0.00001). Conclusion The study of the metabolic relationship between the ET-1 and ACE among coronary patients reveals other therapeutics targets.
Collapse
Affiliation(s)
- Abdelkader Chalghoum
- Laboratory of Biochemistry, Farhat HACHED Hospital, Street Doctor Moreau, 4000, Sousse, Tunisia. .,Valorization and Technology Transfer Space, Center of Biotechnology of Borj Cedria, 2050, HamamLif, Tunisia.
| | - Yosri Noichri
- Laboratory of Biochemistry, Farhat HACHED Hospital, Street Doctor Moreau, 4000, Sousse, Tunisia
| | - Azza Dandana
- Laboratory of Biochemistry, Farhat HACHED Hospital, Street Doctor Moreau, 4000, Sousse, Tunisia
| | - Bruno Baudin
- Department of Biochemistry, Saint-Antoine Hospital, 184 Street Faubourg Saint-Antoine, 75571, Paris, Cedex 12, France
| | - Abdelhédi Miled
- Laboratory of Biochemistry, Farhat HACHED Hospital, Street Doctor Moreau, 4000, Sousse, Tunisia
| | - Salima Ferchichi
- Laboratory of Biochemistry, Farhat HACHED Hospital, Street Doctor Moreau, 4000, Sousse, Tunisia
| |
Collapse
|